Torsten Hoffmann
Corporate Officer/Principal at American Chemical Society
Profile
Torsten Hoffmann is a member of the American Chemical Society and the Swiss Chemical Society.
He was the Managing Director & Chief Scientific Officer at Proteros biostructures GmbH.
He was also the Head-Global Roche Postdoc at Roche Holding AG from 1999 to 2015.
In 2017 to 2018, he was the Chief Operating Officer at Silence Therapeutics Plc.
He was an Associate at The Scripps Research Institute and the Chief Scientific Officer at Oryzon Genomics SA. He was also the Chief Scientific Officer & Executive VP at Zealand Pharma A from 2013 to 2015.
Dr. Hoffmann holds a doctorate degree from the Swiss Federal Institute of Technology.
Currently, he holds positions as a member of the American Chemical Society and the Swiss Chemical Society.
Torsten Hoffmann active positions
| Companies | Position | Start |
|---|---|---|
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Swiss Chemical Society
 Swiss Chemical Society Miscellaneous Commercial ServicesCommercial Services Swiss Chemical Society provides accounting services. The non-profit company is based in Bern, Switzerland. | Corporate Officer/Principal | - |
Former positions of Torsten Hoffmann
| Companies | Position | End |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Chief Operating Officer | 2018-06-20 |
| ZEALAND PHARMA A/S | Chief Tech/Sci/R&D Officer | 2014-12-31 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 2014-12-31 |
| ORYZON GENOMICS S.A. | Chief Tech/Sci/R&D Officer | - |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | - |
Training of Torsten Hoffmann
| Swiss Federal Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| SILENCE THERAPEUTICS PLC | Commercial Services |
| ORYZON GENOMICS S.A. | Health Technology |
| ZEALAND PHARMA A/S | Health Technology |
| Private companies | 3 |
|---|---|
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Commercial Services |
Swiss Chemical Society
Swiss Chemical Society Miscellaneous Commercial ServicesCommercial Services Swiss Chemical Society provides accounting services. The non-profit company is based in Bern, Switzerland. | Commercial Services |
Proteros biostructures GmbH
 Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Health Services |
- Stock Market
- Insiders
- Torsten Hoffmann
